BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION
Back to Cashflow Statement
|
BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION Last 5 Year Cash Flow from Operating Activities History
[Standalone]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Cash Flow from Operating Activities | ₹11 Cr | ₹-42 Cr | ₹12 Cr | ₹34 Cr | ₹-32 Cr |
What is the latest Cash Flow from Operating Activities ratio of BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION ?
Year | Cash Flow from Operating Activities |
---|---|
Mar2023 | ₹11 Cr |
Mar2022 | ₹-42 Cr |
Mar2021 | ₹12 Cr |
Mar2020 | ₹34 Cr |
Mar2019 | ₹-32 Cr |
How is Cash Flow from Operating Activities of BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION Trending?
Years | Cash Flow from Operating Activities | % Change | |
---|---|---|---|
Mar2023 | ₹11 Cr | Positive | |
Mar2022 | ₹-42 Cr | Negative | |
Mar2021 | ₹12 Cr | -65.44 | |
Mar2020 | ₹34 Cr | Positive | |
Mar2019 | ₹-32 Cr | - |
Compare Cash Flow from Operating Activities of peers of BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION | ₹126.2 Cr | 2.9% | -1.9% | 23.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹439,714.0 Cr | 1.1% | 6.8% | 62.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹145,166.0 Cr | 0.3% | 16.8% | 44.8% | Stock Analytics | |
CIPLA | ₹133,402.0 Cr | 2.7% | 6.1% | 33.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹109,604.0 Cr | 0.3% | -4% | 17.1% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹108,608.0 Cr | -0.2% | -6.3% | 77.8% | Stock Analytics |
BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION | 2.9% |
-1.9% |
23.7% |
SENSEX | 1.8% |
3.1% |
23.4% |
You may also like the below Video Courses